Literature DB >> 1919435

Defective intracellular transport as a common mechanism limiting expression of inappropriately paired class II major histocompatibility complex alpha/beta chains.

A J Sant1, L R Hendrix, J E Coligan, W L Maloy, R N Germain.   

Abstract

Distinct combinations of class II major histocompatibility complex (MHC) alpha and beta chains show widely varying efficiencies of cell surface expression in transfected cells. Previous studies have analyzed the regions of the class II chains that are critically involved in this phenomenon of variable expression and have shown a predominant effect of the NH2-terminal domains comprising the peptide-binding site. The present experiments attempt to identify the post-translational defects responsible for this variation in surface class II molecule expression for both interisotypic alpha/beta combinations failing to give rise to any detectable cell membrane molecules (e.g., E alpha A beta k) and intraisotypic pairs with inefficient surface expression (e.g., A alpha d A beta k). The results of metabolic labeling and immunoprecipitation experiments using L cell transfectants demonstrate that in both of these cases, the alpha and beta chains form substantial amounts of stable intracellular dimers. However, the isotype- and allele-mismatched combinations do not show the typical post-translational increases in molecular weight that accompany maturation of the N-linked glycans of class II MHC molecules. Studies with endoglycosidase H reveal that no or little progression to endoglycosidase H resistance occurs for these mismatched dimers. These data are consistent with active or passive retention of relatively stable and long-lived mismatched dimers in a pre-medial-Golgi compartment, possibly in the endoplasmic reticulum itself. This retention accounts for the absent or poor surface expression of these alpha/beta combinations, and suggests that conformational effects of the mismatching in the NH2-terminal domain results in a failure of class II molecules to undergo efficient intracellular transport.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919435      PMCID: PMC2118973          DOI: 10.1084/jem.174.4.799

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  55 in total

Review 1.  T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex.

Authors:  R H Schwartz
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

Review 2.  Polypeptide chain binding proteins: catalysts of protein folding and related processes in cells.

Authors:  J E Rothman
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

Review 3.  Mechanisms of antigen processing.

Authors:  C V Harding; F Leyva-Cobian; E R Unanue
Journal:  Immunol Rev       Date:  1988-12       Impact factor: 12.988

4.  Qualitative and quantitative studies of antigen-presenting cell function by using I-A-expressing L cells.

Authors:  R I Lechler; M A Norcross; R N Germain
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

5.  Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport.

Authors:  M J Gething; K McCammon; J Sambrook
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  Posttranslational association of immunoglobulin heavy chain binding protein with nascent heavy chains in nonsecreting and secreting hybridomas.

Authors:  D G Bole; L M Hendershot; J F Kearney
Journal:  J Cell Biol       Date:  1986-05       Impact factor: 10.539

7.  Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.

Authors:  J M Buerstedde; L R Pease; A E Nilson; M P Bell; C Chase; G Buerstedde; D J McKean
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

8.  Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA.

Authors:  V Lotteau; J Sands; L Teyton; P Turmel; D Charron; J L Strominger
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

9.  Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules.

Authors:  I J Griffith; N Nabavi; Z Ghogawala; C G Chase; M Rodriguez; D J McKean; L H Glimcher
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

10.  Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain.

Authors:  R P Sekaly; C Tonnelle; M Strubin; B Mach; E O Long
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  18 in total

1.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.

Authors:  M S Anderson; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

3.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

4.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

5.  Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.

Authors:  G Zhong; C Reis e Sousa; R N Germain
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA.

Authors:  Hiroko Miyadera; Jun Ohashi; Åke Lernmark; Toshio Kitamura; Katsushi Tokunaga
Journal:  J Clin Invest       Date:  2014-12-08       Impact factor: 14.808

7.  Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides (CLIP).

Authors:  G Zhong; F Castellino; P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

8.  Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones.

Authors:  J Arroyo; R Díez-Orejas; A M Alvarez; S Shaw; M Sánchez-Pérez
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

9.  HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.

Authors:  Abigail I Guce; Sarah E Mortimer; Taejin Yoon; Corrie A Painter; Wei Jiang; Elizabeth D Mellins; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2012-12-09       Impact factor: 15.369

10.  Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain.

Authors:  C Bonnerot; M S Marks; P Cosson; E J Robertson; E K Bikoff; R N Germain; J S Bonifacino
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.